Suppr超能文献

印度中央邦穆克蒂按效付费模式下营养补充及辅助干预对结核病治疗效果的影响与成本效益评估:一项研究方案

Impact and cost-effectiveness evaluation of nutritional supplementation and complementary interventions for tuberculosis treatment outcomes under mukti pay-for-performance model in Madhya Pradesh, India: A study protocol.

作者信息

Prinja Shankar, Sharma Atul, Nadipally Sudheer, Rana Saroj Kumar, Bahuguna Pankaj, Rao Neeta, Chakraborty Gautam, Shankar Manjunath, Rai Varsha

机构信息

Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Partnership for Affordable Healthcare, Access and Longevity, IPE Global Pvt. Ltd, New Delhi, India.

出版信息

Int J Mycobacteriol. 2023 Jan-Mar;12(1):82-91. doi: 10.4103/2212-5531.307071.

Abstract

BACKGROUND

A.

UNLABELLED

"pay-for-performance" (P4P) intervention model for improved tuberculosis (TB) outcomes, called "Mukti," has been implemented in an underdeveloped tribal area of central India. The target of this project is to improve nutritional status, quality of life (QoL), and treatment outcomes of 1000 TB patients through four interventions: food baskets, personal counseling, peer-to-peer learning and facilitation for linkage to government schemes. The current study aims to assess the success of this model by evaluating its impact and cost-effectiveness using a quasi-experimental approach.

METHODS

Data for impact assessment have been collected from 1000 intervention and control patients. Study outcomes such as treatment completion, sputum negativity, weight gain, and health-related QoL will be compared between matched samples. Micro costing approach will be used for assessing the cost of routine TB services provision under the national program and the incremental cost of implementing our interventions. A decision and Markov hybrid model will estimate long-term costs and health outcomes associated with the use of study interventions. Measures of health outcomes will be mortality, morbidity, and disability. Cost-effectiveness will be assessed in terms of incremental cost per quality-adjusted life-years gained and cost per unit increase in patient weight in intervention versus control groups.

RESULTS

The evidence generated from the present study in terms of impact and cost-effectiveness estimates will thus help to identify not only the effectiveness of these interventions but also the optimal mode of financing such measures. Our estimates on scale-up costs for these interventions will also help the state and the national government to consider scale-up of such interventions in the entire state or country.

DISCUSSION

The study will generate important evidence on the impact of nutritional supplementation and other complementary interventions for TB treatment outcomes delivered through P4P financing models and on the cost of scaling up these to the state and national level in India.

摘要

背景

A.

未标注

一种名为“穆克蒂”的旨在改善结核病(TB)治疗效果的“按效付费”(P4P)干预模式已在印度中部一个欠发达的部落地区实施。该项目的目标是通过四项干预措施改善1000名结核病患者的营养状况、生活质量(QoL)和治疗效果:食品篮、个人咨询、 peer-to-peer学习以及促进与政府计划的联系。本研究旨在通过采用准实验方法评估其影响和成本效益来评估该模式的成功性。

方法

已从1000名干预组和对照组患者中收集了影响评估数据。将在匹配样本之间比较治疗完成情况、痰菌转阴、体重增加和与健康相关的生活质量等研究结果。微观成本核算方法将用于评估国家项目下提供常规结核病服务的成本以及实施我们干预措施的增量成本。决策和马尔可夫混合模型将估计与使用研究干预措施相关的长期成本和健康结果。健康结果的衡量指标将是死亡率、发病率和残疾情况。将根据干预组与对照组每获得一个质量调整生命年的增量成本以及患者体重每增加一个单位的成本来评估成本效益。

结果

本研究在影响和成本效益估计方面产生的证据不仅将有助于确定这些干预措施的有效性,还将有助于确定为这些措施融资的最佳模式。我们对这些干预措施扩大规模成本的估计也将有助于邦政府和中央政府考虑在整个邦或全国扩大此类干预措施。

讨论

该研究将产生关于通过P4P融资模式提供的营养补充和其他补充干预措施对结核病治疗效果的影响以及将这些措施扩大到印度邦和国家层面的成本的重要证据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验